Ignite Creation Date:
2025-12-24 @ 7:35 PM
Ignite Modification Date:
2025-12-25 @ 5:16 PM
Study NCT ID:
NCT05179603
Status:
TERMINATED
Last Update Posted:
2025-12-24
First Post:
2021-12-16
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of SAR444245 With or Without Other Anticancer Therapies for the Treatment of Adults and Adolescents With Relapsed or Refractory B Cell Lymphoma (Master Protocol) [Pegathor Lymphoma 205]
Sponsor:
Sanofi
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-07
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-09-06
Completion Date Type:
ACTUAL
First Submit Date:
2021-12-16
First Submit QC Date:
None
Study First Post Date:
2022-01-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-07-31
Results First Submit QC Date:
None
Results First Post Date:
2025-10-02
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2025-10-02
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2025-12-05
Last Update Post Date:
2025-12-24
Last Update Post Date Type:
ACTUAL